Articles By Shawn Mulcahy
Compared to the last quarter, spending on cannabis-related issues is down somewhat, though some entities are pushing for coronavirus relief.
Two groups, including the campaign arm of The Heritage Foundation, joined an anti-cannabis veteran to oppose cannabis legislation in Congress.
Companies and organizations spent nearly $11 million on federal lobbying alone, vastly outpacing previous years. But given the coronavirus, 2020 is a mystery.
Lawmakers, regulators, and the courts are reshaping the industry, and the industry would like to be heard. But will the economy hold?
The legislature adjourned without a single hearing on a bill to legalize adult use cannabis. Its sponsor remains unfazed.
One of the largest and oldest CBD companies hopes to shape the state’s hemp industry, expected to be among the top in the nation.
Syngenta, which rejected an acquisition by Monsanto in 2015, is the latest major agriculture company monitoring the newly-legal market.
The supermarket giant started carrying CBD products last year. Now, it’s pressing the federal government on the issue.
Make It Legal Florida shattered previous fundraising efforts last month. But the odds the adult use proposal will make it onto November’s ballot remain slim.